Cargando…
Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors
BACKGROUND: Sodium-Glucose CoTransporter-2 (SGLT2) inhibitors, the -flozin group of drugs, which block glucose reuptake in the renal proximal tubule, are being increasingly used off-label to treat horses with refractory hyperinsulinemia. After 2 years of use by animals in our group, a horse on canag...
Autores principales: | Kellon, Eleanor M., Gustafson, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072834/ https://www.ncbi.nlm.nih.gov/pubmed/37026076 http://dx.doi.org/10.5455/OVJ.2023.v13.i3.14 |
Ejemplares similares
-
Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis
por: Kellon, Eleanor M., et al.
Publicado: (2022) -
Possible dysmetabolic hyperferritinemia in hyperinsulinemic horses
por: Kellon, Eleanor M., et al.
Publicado: (2019) -
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia
por: Nasiri, Ali R., et al.
Publicado: (2019) -
SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients
por: Ray, Evan C., et al.
Publicado: (2020) -
The Gln27Glu Polymorphism in β2-Adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis
por: Daghestani, Maha H, et al.
Publicado: (2010)